Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04548765 · ClinicalTrials.gov registry record · NA

Evaluation of Letters Promoting Colorectal Cancer Testing

A NA study, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
14,644
Enrollment target

NCT04548765: Completed NA study, sponsored by Geisinger Clinic.

NCT04548765 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 14,644 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (944% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04548765, a NA study, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
14,644 participants
Enrollment target

Study Summary

In this evaluation, 4 different versions of letters are being sent with mailers promoting colorectal cancer screening with an at-home test. The researchers hypothesize that the use of behavioral nudges in the message should lead to increased colorectal cancer screening (either with the at-home test or a colonoscopy).

Primary Outcome

Binary variable indicating whether a valid FIT kit was returned for testing

Interventions

  • BEHAVIORAL Letter
  • BEHAVIORAL Loss Frame and Fear Appeals
  • BEHAVIORAL Transparency
  • BEHAVIORAL Default Effect and Presentation of Alternatives
  • BEHAVIORAL Enhanced Fear Appeals and Decoy Effect

Trial Details

FieldValue
Enrollment Target 14,644 participants
Start Date 2020-07-24
Est. Completion 2021-07-23
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT04548765 record still lists

NCT04548765 is an interventional study that assigns participants to a tested intervention. Its 14,644 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (944% higher).

The record links to 0 conditions, and to 5 interventions - of which Letter is the first listed.

NCT04548765 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04548765 about?

NCT04548765 is a clinical study titled "Evaluation of Letters Promoting Colorectal Cancer Testing". In this evaluation, 4 different versions of letters are being sent with mailers promoting colorectal cancer screening with an at-home test. The researchers hypothesize that the use of behavioral nudges in the message should lead to increased colorectal cancer screening (either with the at-home test ...

What is the current status of trial NCT04548765?

This trial is currently completed. It is a NA study. The enrollment target is 14,644 participants. The study started on 2020-07-24. Estimated completion is 2021-07-23.

What interventions are being tested in trial NCT04548765?

The interventions under investigation include: Letter (BEHAVIORAL), Loss Frame and Fear Appeals (BEHAVIORAL), Transparency (BEHAVIORAL), Default Effect and Presentation of Alternatives (BEHAVIORAL), Enhanced Fear Appeals and Decoy Effect (BEHAVIORAL).

Who is sponsoring clinical trial NCT04548765?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04548765's enrollment target sits among peer trials

14,644 13th of 2000 higher than 1,988 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05359016 · 14,600 participants · NA

    Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

  • NCT06849869 · 14,820 participants · NA

    Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change

  • NCT05591066 · 14,400 participants · NA

    The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

  • NCT00857922 · 15,000 participants

    Neurosciences Research Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04548765, the US trial registry maintained by the National Library of Medicine. NCT04548765 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.